Zhejiang Ausun Pharmaceutical Co., Ltd.

¥7.17As of Sun 8 Nov 2026, 12:00 UTC
SSE:603229Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR 4.08%
Div yield 0.89%
ROE (0.20%)
Biotechnology
Beta (5Y) 0.03
PE TTM —
TSR TTM (29.53%)
Mkt cap ¥5.916B
ROIC 0.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.61
6.20%
(0.26%)
Hold 10|11|1|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.09
0.09
10.57%
6.81%
17.39%
14.19%
Revenue¥M
767.1
771.6
785.6
796.5
18.73%
13.12%
9.14%
7.48%
Peers (US$886.8M)
Cap (US$)
PE
925.5M
28.74x
Capital
TTM
5Y
10Y
Leveragex
0.338
0.072
0.058
EBIT/Intx
1.444
0.430
0.389
Own earn%
(27.21)
4.16
5.49
Sh yield%
32.97
6.94
6.28
Owners
Insiders/Inst%
11.70
38.97
Short interest%
3.71
SBC / revenue%
4.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
14–23
$1 testx
0.1
Incr. ROIC%
22